Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated

Ha Won Kim1, Husnain K Haider, Shujia Jiang

  • 1Department of Pathology, University of Cincinnati, Cincinnati, Ohio 45267, USA.

Insights

Ischemic preconditioning (IP) enhances mesenchymal stem cell (MSC) survival by activating survival pathways and inducing miR-210, which targets FLASH/Casp8ap2. This strategy improves stem cell survival in myocardial infarction models.

Area of Science:

  • Stem cell biology
  • Molecular biology
  • Cardiovascular research

Background:

  • MicroRNAs regulate gene expression, but their role in stem cell ischemic preconditioning is unclear.
  • Ischemic preconditioning (IP) aims to protect cells from ischemic injury.

Purpose of the Study:

  • To investigate the role of microRNAs, specifically miR-210, in the ischemic preconditioning of mesenchymal stem cells (MSCs).
  • To elucidate the protective mechanisms of IP in MSCs and their efficacy in a myocardial infarction model.

Main Methods:

  • MSCs were subjected to ischemic preconditioning (IP) using cycles of ischemia/reoxygenation (I/R).
  • Apoptosis, cell signaling pathways (Akt, ERK1/2), and hypoxia-inducible factor-1alpha (HIF-1alpha) were assessed.
  • miR-210 expression and its target gene, FLASH/Casp8ap2, were analyzed.
  • In vivo studies utilized a rat model of acute myocardial infarction.

Main Results:

  • IP significantly enhanced MSC survival under anoxia and improved engraftment in infarcted hearts.
  • IP activated Akt, ERK1/2, and HIF-1alpha, leading to miR-210 induction.
  • Inhibition of HIF-1alpha or miR-210 abolished the protective effects of IP.
  • miR-210 directly targeted FLASH/Casp8ap2, suppressing its expression and reducing apoptosis.
  • Multiple short I/R cycles were more effective than single prolonged hypoxia.

Conclusions:

  • Ischemic preconditioning protects MSCs via miR-210 induction, which suppresses FLASH/Casp8ap2.
  • This miR-210-mediated pathway is crucial for stem cell survival under ischemic stress.
  • IP using multiple short I/R episodes is a promising strategy to enhance stem cell therapy for myocardial infarction.